ACIP Update to the Evidence to Recommendations for a 2nd
As the 2nd booster is already authorized and available, recommendations can rapidly adjust if COVID-19 epidemiology changes in the future. The current recommendation
As the 2nd booster is already authorized and available, recommendations can rapidly adjust if COVID-19 epidemiology changes in the future. The current recommendation
Adults who have had 3 or more doses of polio vaccine in the past and are at increased risk of exposure to poliovirus may receive one lifetime booster dose of IPV.
The 2025–2026 COVID-19 vaccine is recommended for people ages 6 months and older based on individual-based decision-making (also known as shared clinical decision
CDC developed the Booster Seat Planning Guide to assist States, Tribes, Localities, and Territories (STLTs) with assessing, planning, and implementing improved booster seat laws to
CDC''s Booster Seat Planning Guide can assist states, tribes, localities, and territories with assessing, planning, and implementing improved booster seat laws to reduce
People who are up to date with their COVID-19 vaccine have lower risk of severe illness.
Also, adults should receive a booster dose of either Tdap or Td (a different vaccine that protects against tetanus and diphtheria but not pertussis) every 10 years, or after 5 years
October 23, 2024 - Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices'' (ACIP) recommendation for people 65 years and older and those
Stay up-to-date on recommended vaccines. View and print CDC immunization schedules for adults.
Safety considerations for COVID-19 vaccines In clinical trials of COVID-19 vaccines, post-vaccination reactions were generally similar. While the frequency of some reactions
PDF version includes complete article with source references. Suitable for printing and offline reading.